LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for A2 Biotherapeutics, Inc. and Millions of Other Companies

Sign up for full access to A2 Biotherapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Cutting-edge Cancer Therapies A2 Biotherapeutics specializes in developing targeted cell therapies for cancer treatment, particularly focusing on solid tumors. This innovative approach provides a unique selling point for healthcare institutions seeking advanced treatment options for their patients.

Promising Clinical Trials The recent launch of the EVEREST-2 Phase 1 clinical trial for a novel mesothelin logic-gated CAR T therapy presents an opportunity for collaborations with medical centers looking to participate in cutting-edge research and offer patients access to the latest cancer treatment options.

New Leadership Impact With the appointment of James Robinson as the new Chief Executive Officer, A2 Biotherapeutics may be open to partnerships or collaborations under fresh leadership. Business development professionals could leverage this change to initiate discussions around potential joint ventures or business opportunities.

Innovative T-cell Platform The launch of the Tmod logic-gated T-cell platform by A2 Biotherapeutics offers a unique tool for healthcare providers seeking state-of-the-art solutions for differentiating between cancer cells and healthy cells. This platform can be positioned as a competitive advantage in sales pitches to oncology centers and research institutions.

Strategic Collaboration Opportunity The collaboration between A2 Biotherapeutics and Merck to develop allogeneic cell therapy for solid tumor cancers signals a willingness to partner with industry leaders. Sales professionals could explore potential partnership opportunities with pharmaceutical companies looking to expand their oncology product portfolios.

Similar companies to A2 Biotherapeutics, Inc.

✕

Access Insights for A2 Biotherapeutics, Inc. and Millions of Other Companies

Sign up for full access to A2 Biotherapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

A2 Biotherapeutics, Inc. Tech Stack

A2 Biotherapeutics, Inc. uses 8 technology products and services including Cloudflare CDN, Google Font API, TweenMax, and more. Explore A2 Biotherapeutics, Inc.'s tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • Google Font API
    Font Scripts
  • TweenMax
    Javascript Frameworks
  • React
    Javascript Frameworks
  • OWL Carousel
    Javascript Libraries
  • Slick
    Javascript Libraries
  • Java
    Programming Languages
  • Bootstrap
    UI Frameworks

Media & News

A2 Biotherapeutics, Inc.'s Email Address Formats

A2 Biotherapeutics, Inc. uses at least 2 format(s):
A2 Biotherapeutics, Inc. Email FormatsExamplePercentage
FLast@a2bio.comJDoe@a2bio.com
47%
Last@a2bio.comDoe@a2bio.com
6%
FLast@a2bio.comJDoe@a2bio.com
47%
FLast@a2biotherapeutics.comJDoe@a2biotherapeutics.com
97%
FMiddleLast@a2biotherapeutics.comJMichaelDoe@a2biotherapeutics.com
2%
LFirst@a2biotherapeutics.comDJohn@a2biotherapeutics.com
1%

Frequently Asked Questions

Where is A2 Biotherapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc.'s main headquarters is located at 30301 Agoura Road Suite 210 Agoura Hills, CA 91301 US. The company has employees across 1 continents, including North America.

What is A2 Biotherapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc.'s official website is a2bio.com and has social profiles on LinkedIn.

How much revenue does A2 Biotherapeutics, Inc. generate?

Minus sign iconPlus sign icon As of September 2024, A2 Biotherapeutics, Inc.'s annual revenue reached $35M.

What is A2 Biotherapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does A2 Biotherapeutics, Inc. have currently?

Minus sign iconPlus sign iconAs of September 2024, A2 Biotherapeutics, Inc. has approximately 132 employees across 1 continents, including North America. Key team members include Chief Executive Officer: J. R.Chief Financial Officer: T. L.Chief Business Officer: V. J.. Explore A2 Biotherapeutics, Inc.'s employee directory with LeadIQ.

What industry does A2 Biotherapeutics, Inc. belong to?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc. operates in the Biotechnology Research industry.

What technology does A2 Biotherapeutics, Inc. use?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc.'s tech stack includes Cloudflare CDNGoogle Font APITweenMaxReactOWL CarouselSlickJavaBootstrap.

What is A2 Biotherapeutics, Inc.'s email format?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc.'s email format typically follows the pattern of . Find more A2 Biotherapeutics, Inc. email formats with LeadIQ.

How much funding has A2 Biotherapeutics, Inc. raised to date?

Minus sign iconPlus sign icon As of September 2024, A2 Biotherapeutics, Inc. has raised $62M in funding. The last funding round occurred on Dec 19, 2022 for $62M.

When was A2 Biotherapeutics, Inc. founded?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc. was founded in 2018.
A2 Biotherapeutics, Inc.

A2 Biotherapeutics, Inc.

Biotechnology ResearchCalifornia, United States51-200 Employees

A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. We are focused on the next frontier in cell therapy: solid tumors.

A2 engineers T cells that target the loss of genetic material in tumors, enabling the selective killing of tumor cells while leaving normal cells unharmed.

The company was founded in 2018 by Alexander Kamb, Michael Gallo and Paul Kang and has raised $136M since inception. Our investors include The Column Group, Vida Ventures, Samsara BioCapital, Nextech Invest, Casdin Capital, Euclidean Capital, UC Investments (Office of the Chief Investment Officer of the Regents) and Hartford HealthCare Endowment.

✕

Access Insights for A2 Biotherapeutics, Inc. and Millions of Other Companies

Sign up for full access to A2 Biotherapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
30301 Agoura Road Suite 210 Agoura Hills, CA 91301 US
Website
a2bio.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $62M

    A2 Biotherapeutics, Inc. has raised a total of $62M of funding over 4 rounds. Their latest funding round was raised on Dec 19, 2022 in the amount of $62M.

  • $10M$50M

    A2 Biotherapeutics, Inc.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $62M

    A2 Biotherapeutics, Inc. has raised a total of $62M of funding over 4 rounds. Their latest funding round was raised on Dec 19, 2022 in the amount of $62M.

  • $10M$50M

    A2 Biotherapeutics, Inc.'s revenue is in the range of $10M$50M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for A2 Biotherapeutics, Inc. and Millions of Other Companies

Sign up for full access to A2 Biotherapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.